The U.K. Chancellor of the Exchequer, George Osborne, is increasing the budget of the Serious Fraud Office (SFO) as political pressures are heating up around allegations of banks manipulating Libor rates. The additional funds are to go toward the preparation of criminal investigations into the charges. The agency’s budget in 2008 was £52 million; this year, it is £32 million. The SFO had unsuccessfully lobbied the government for a greater budget.
Days earlier, the Financial Times reported that the SFO had decided last year to turn down opening a criminal probe because of limited resources. Richard Alderman, the former director of the SFO, had determined that the agency’s budget was too limited and that the Office of Fair Trading and the Financial Services Authority would be in a better position to handle the probe.
Full content: Financial Times
Related content: How Far Can Screens Go in Distinguishing Explicit from Tacit Collusion? New Evidence on the Libor Setting
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas